Penn Davis McFarland’s Merck MRK Stock Holding History

Penn Davis McFarland’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,022	Closed	-$267K	–	46
2024 Q1	$267K	Hold	2,022	–	–	0.04%	44
2023 Q4	$220K	Buy	+2,022	New	+$210K	0.04%	46
2020 Q1	–	Sell	-2,410	Closed	-$209K	–	48
2019 Q4	$209K	Buy	+2,410	New	+$198K	0.06%	44

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Penn Davis McFarland's MRK Position: Q2 2024 in Review

Penn Davis McFarland sold out of Merck (MRK) in Q2 2024, closing a stake of 2,022 shares — an estimated $267K sold.

Penn Davis McFarland first reported a position in MRK in Q4 2019 and held it in 3 quarters. The position peaked at $267K in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Penn Davis McFarland reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
Penn Davis McFarland sold 2,022 Merck shares in Q2 2024, an estimated $267K.
Penn Davis McFarland first reported a position in Merck in Q4 2019 and held it in 3 quarters.
Penn Davis McFarland's Merck position peaked at $267K in Q1 2024.
3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Penn Davis McFarland's 13F filing for Q2 2024, filed 19 Jul 2024.